Journey Medical Corp (DERM) — Strategic Asset Allocation Index
Journey Medical Corp (DERM) has a Strategic Asset Allocation Index of 2920.0% as of June 2023. Strategic assets (PP&E of $146.00K plus long-term investments of $-) total $146.00K, measured against net assets of $5.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Journey Medical Corp (DERM) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Journey Medical Corp Strategic Asset Allocation Index (2019–2022)
This chart shows how Journey Medical Corp's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 2920.0%, representing strategic assets of $146.00K against net assets of $5.00K USD. See Journey Medical Corp (DERM) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Journey Medical Corp (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Journey Medical Corp from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Journey Medical Corp (DERM) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.1% | $189.00K | $189.00K | $- | $16.98 Million | ▲ +0.9 pp |
| 2021 | 0.2% | $89.00K | $89.00K | $- | $42.04 Million | ▼ -1.5 pp |
| 2020 | 1.7% | $175.00K | $175.00K | $- | $10.29 Million | ▼ -1.5 pp |
| 2019 | 3.2% | $89.00K | $89.00K | $- | $2.75 Million | — |